Efficacy and tolerability of a 4-month ofloxacin-containing regimen compared to a 6-month regimen in the treatment of patients with superficial lymph node tuberculosis: a randomized trial

Hissar, Syed and Velayutham, Banurekha and Tamizhselvan, Manoharan and Rathinam, Sridhar and Arunbabu, Chinnadurai and Bharathi Vidhya, Jayanthi and Vargunapandian, Gurusamy and Sundararajaperumal, Anandakrishnan and Narayan Sivaramakrishnan, Gomathi and Silambu Chelvi, K and Ramesh, Paranchi Murugesan and Arun, Damodharan and Devarajulu Reddy, Sirasanambati and Paul Kumaran, Paramasivam and Makesh Kumar, Marimuthu and Kalaiselvi, Dharuman and Hanna, Luke Elizabeth and Hemanth Kumar, AK and Gowrisankar, Alagarsamy and Rajavelu, Ramasamy and Jayabal, Lavanya and Ponnuraja, Chinnaiyan and Baskaran, Dhanaraj (2024) Efficacy and tolerability of a 4-month ofloxacin-containing regimen compared to a 6-month regimen in the treatment of patients with superficial lymph node tuberculosis: a randomized trial. Efficacy and tolerability of a 4-month ofloxacin-containing regimen compared to a 6-month regimen in the treatment of patients with superficial lymph node tuberculosis: a randomized trial, 24(1) (729).

Text 202416.pdf - Published Version Download (1MB)

Abstract

Tuberculosis (TB) lymphadenitis is the most common form of extra-pulmonary TB, and the treatment duration is six months. This non-inferiority based randomized clinical trial in South India evaluated the efficacy and safety of a four-month ofloxacin containing regimen in tuberculosis lymphadenitis (TBL) patients.

Affiliation:	ICMR- National Institute for Research in Tuberculosis
Item Type:	Article
Uncontrolled Keywords:	Biopsy; Extra pulmonary tuberculosis; Lymphadenitis; Ofloxacin; Tuberculosis.
Subjects:	Tuberculosis > Clinical Research
Divisions:	Clinical Research
Depositing User:	Mrs. N Lakshmi
Date Deposited:	01 Aug 2024 12:07
Last Modified:	01 Aug 2024 12:07
URI:	http://eprints.nirt.res.in/id/eprint/2010

Actions (login required)

View Item